Craig S. Gilgallon

Craig S. Gilgallon is a Co-Founder of Cingulate Therapeutics and serves as General Counsel and Chief Compliance Officer. As such, he directs and manages all aspects of the company’s legal needs, corporate governance, and compliance. Concurrently, Craig S. Gilgallon is one of the founding members and partner of Pawar Gilgallon & Rudy, LLC, a full-service business practice where he is dedicated to the efficient handling of transactional matters.

Mr. Gilgallon has more than twenty years of experience in transactional and corporate law. He has advised and represented clients from mid-sized and early-stage to larger multi-nationals in any type and size transactions, including mergers, acquisitions, divestitures, corporate recapitalizations, restructurings and reorganizations; alternative entities (partnerships, limited liability companies, business trusts, etc.); joint ventures and employment, licensing and other corporate arrangements; private and public placements of debt and equity securities; private equity investments; initial public offerings; domestic tax-advantaged transactions; project finance; etc.

Mr. Gilgallon received a B.S. from Ithaca College and received his Juris Doctorate from the Thomas Jefferson School of Law.